Literature DB >> 11912118

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Andrew J Hughes1, Susan E Daniel, Yoav Ben-Shlomo, Andrew J Lees.   

Abstract

We have reviewed the clinical and pathological diagnoses of 143 cases of parkinsonism seen by neurologists associated with the movement disorders service at The National Hospital for Neurology and Neurosurgery in London who came to neuropathological examination at the United Kingdom Parkinson's Disease Society Brain Research Centre, over a 10-year period between 1990 and the end of 1999. Seventy-three (47 male, 26 female) cases were diagnosed as having idiopathic Parkinson's disease (IPD) and 70 (42 male, 28 female) as having another parkinsonian syndrome. The positive predictive value of the clinical diagnosis for the whole group was 85.3%, with 122 cases correctly clinically diagnosed. The positive predictive value of the clinical diagnosis of IPD was extremely high, at 98.6% (72 out of 73), while for the other parkinsonian syndromes it was 71.4% (50 out of 70). The positive predictive values of a clinical diagnosis of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) were 85.7 (30 out of 35) and 80% (16 out of 20), respectively. The sensitivity for IPD was 91.1%, due to seven false-negative cases, with 72 of the 79 pathologically established cases being diagnosed in life. For MSA, the sensitivity was 88.2% (30 out of 34), and for PSP it was 84.2% (16 out of 19). The diagnostic accuracy for IPD, MSA and PSP was higher than most previous prospective clinicopathological series and studies using the retrospective application of clinical diagnostic criteria. The seven false-negative cases of IPD suggest a broader clinical picture of disease than previously thought acceptable. This study implies that neurologists with particular expertise in the field of movement disorders may be using a method of pattern recognition for diagnosis which goes beyond that inherent in any formal set of diagnostic criteria.

Entities:  

Mesh:

Year:  2002        PMID: 11912118     DOI: 10.1093/brain/awf080

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  297 in total

Review 1.  Circulating MicroRNA as Potential Source for Neurodegenerative Diseases Biomarkers.

Authors:  Ying Zi; Zhongmin Yin; Weizhong Xiao; Xinwei Liu; Zhixiang Gao; Li Jiao; Lianfu Deng
Journal:  Mol Neurobiol       Date:  2014-11-04       Impact factor: 5.590

Review 2.  Modelling the cost effectiveness of treatments for Parkinson's disease: a methodological review.

Authors:  Judith Dams; Bernhard Bornschein; Jens Peter Reese; Annette Conrads-Frank; Wolfgang H Oertel; Uwe Siebert; Richard Dodel
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

3.  Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome.

Authors:  Naomi Kouri; Melissa E Murray; Anhar Hassan; Rosa Rademakers; Ryan J Uitti; Bradley F Boeve; Neill R Graff-Radford; Zbigniew K Wszolek; Irene Litvan; Keith A Josephs; Dennis W Dickson
Journal:  Brain       Date:  2011-09-20       Impact factor: 13.501

Review 4.  Screening questionnaires for parkinsonism: a systematic review.

Authors:  Nabila Dahodwala; Andrew Siderowf; Mona Baumgarten; Aaron Abrams; Jason Karlawish
Journal:  Parkinsonism Relat Disord       Date:  2011-09-17       Impact factor: 4.891

5.  Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.

Authors:  Hongliu Ding; Alison K Sarokhan; Sarah S Roderick; Rachit Bakshi; Nancy E Maher; Paymon Ashourian; Caroline G Kan; Sunny Chang; Andrea Santarlasci; Kyleen E Swords; Bernard M Ravina; Michael T Hayes; U Shivraj Sohur; Anne-Marie Wills; Alice W Flaherty; Vivek K Unni; Albert Y Hung; Dennis J Selkoe; Michael A Schwarzschild; Michael G Schlossmacher; Lewis R Sudarsky; John H Growdon; Adrian J Ivinson; Bradley T Hyman; Clemens R Scherzer
Journal:  Mov Disord       Date:  2011-09-23       Impact factor: 10.338

6.  Elevated synchrony in Parkinson disease detected with electroencephalography.

Authors:  Nicole C Swann; Coralie de Hemptinne; Adam R Aron; Jill L Ostrem; Robert T Knight; Philip A Starr
Journal:  Ann Neurol       Date:  2015-09-02       Impact factor: 10.422

Review 7.  Advances in Biomarker Research in Parkinson's Disease.

Authors:  Shyamal H Mehta; Charles H Adler
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

8.  Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease.

Authors:  Kelly Claire Simon; Honglei Chen; Michael Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2007-08-29       Impact factor: 9.910

Review 9.  α-Synuclein nonhuman primate models of Parkinson's disease.

Authors:  David J Marmion; Jeffrey H Kordower
Journal:  J Neural Transm (Vienna)       Date:  2017-04-22       Impact factor: 3.575

Review 10.  Parkinsonian syndromes.

Authors:  David R Williams; Irene Litvan
Journal:  Continuum (Minneap Minn)       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.